S.Biomedics Co., Ltd.
🇰🇷South Korea
Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of A9-DPC in SB-PD-001 Study
Not Applicable
Active, not recruiting
- Conditions
- Parkinson's Disease
- Interventions
- Biological: Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_Low DoseBiological: Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_High Dose
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06477744
- Locations
- 🇰🇷
Yonsei Universitiy Health System, Severance Hospital, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
Phase 1
Active, not recruiting
- Conditions
- Parkinson's Disease
- Interventions
- Biological: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) High DoseBiological: Allogenic embryonic stem cell-derived A9 dopamine progenitor cell (A9-DPC) Low Dose
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05887466
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet
Phase 1
Recruiting
- Conditions
- Crow's Feet
- Interventions
- Biological: Clusters of Autologous Dermal FibroblastsOther: Placebo
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT04818203
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
Phase 1
Recruiting
- Conditions
- Spinal Cord Injury, AcuteSpinal Cord Injury at C5-C7 Level With Complete LesionSpinal Cord Injury at C4 Level With Complete Lesion
- Interventions
- Biological: Neural precursor cells derived from human embryonic stem cell line
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT04812431
- Locations
- 🇰🇷
Ajou University Hospital, Suwon, Gyeonggido, Korea, Republic of
🇰🇷Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia
Phase 1
Active, not recruiting
- Conditions
- Critical Limb Ischemia
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- S.Biomedics Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04661644
© Copyright 2025. All Rights Reserved by MedPath